Stage IV Lymphoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma (NCT03229278) | Rutgers, The State University of New Jersey | 2017-10-03 |
Track Stage IV Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.